Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II neoadjuvant cisplatin, gemcitabine and sunitinib before radical cystectomy for bladder transitional cell carcinoma
2008-006214-26Phase 2Terminated
- Sponsor
- Hoosier Cancer Research Network
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine, cisplatin and sunitinib in bladder cancer, sponsored by Hoosier Cancer Research Network. Primary endpoint: Pathological complete response rate at cystectomy. Started May 2009; status: terminated.
02
Drugs
gemcitabinecisplatinsunitinib
03
Conditions
bladder cancer
Beyond the preview
Go deeper on 2008-006214-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006214-26.